111 (YI) EBT (2017 - 2025)
111's (YI) quarterly EBT came in at -$928000.0 in Q4 2025, up 46.02% year-on-year from -$635550.6 in Q4 2024, and down 357.14% quarter-over-quarter from -$203000.0 in Q3 2025.
111 (YI) EBT (2017 - 2025) Analysis & Trends
111 has disclosed EBT across 9 years of filings, most recently posting -$928000.0 for Q4 2025.
- EBT for Q4 2025 came in at -$928000.0, up 46.02% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.1 million (down 10.14% YoY), and the FY2025 annual result was -$3.2 million, down 13.51% from the prior year.
- EBT came in at -$928000.0 for Q4 2025 at 111, down from -$203000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of -$203000.0 in Q3 2025 to a low of -$28.9 million in Q4 2023.
- The 5-year median for EBT is -$8.8 million (2023), against an average of -$10.4 million.
- Across the five-year window, EBT surged 95.67% in 2024 and sank 262.5% in 2025, its largest moves.
- 111's EBT stood at -$16.0 million in 2021, then advanced by 5.5% to -$15.1 million in 2022, then tumbled by 91.43% to -$28.9 million in 2023, then soared by 94.05% to -$1.7 million in 2024, then jumped by 46.02% to -$928000.0 in 2025.
- The last three EBT figures came in at -$928000.0 (Q4 2025), -$203000.0 (Q3 2025), and -$1.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.13 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 2.09 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 392.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 150.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | -16.25 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -8.94 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -928,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -2.81 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -203,000.00 |
| Jun 30, 2025 | -1.02 Mn |
| Mar 31, 2025 | -1.00 Mn |
| Dec 31, 2024 | -1.72 Mn |
| Sep 30, 2024 | -495,000.00 |
| Jun 30, 2024 | -280,000.00 |
| Mar 31, 2024 | -365,000.00 |
| Dec 31, 2023 | -28.88 Mn |
| Sep 30, 2023 | -11.43 Mn |
| Jun 30, 2023 | -6.26 Mn |
| Mar 31, 2023 | -2.82 Mn |
| Dec 31, 2022 | -15.09 Mn |
| Sep 30, 2022 | -12.12 Mn |
| Jun 30, 2022 | -12.66 Mn |
| Mar 31, 2022 | -15.93 Mn |
| Dec 31, 2021 | -15.97 Mn |
| Sep 30, 2021 | -25.73 Mn |
| Jun 30, 2021 | -28.50 Mn |
| Mar 31, 2021 | -25.87 Mn |